Showing results (251-260 of 369) with videos related to
Sort By:
Pageof 37
JAMA Oncology|January 28, 2021
An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income CountriesJ Connor Wells, Shubham Sharma, Joseph C Del Paggio, et al.Journal of the National Cancer Institute|May 23, 2025
Analysis of 2023 World Health Organization cancer Essential Medicines List and concordance with resource stratified guidelinesBrooke E Wilson, Kristin Wright, Manju Sengar, et al.The Lancet. Oncology|June 3, 2023
Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional studyKristina Jenei, Adam J N Raymakers, Arnaud Bayle, et al.Journal of Global Oncology|September 23, 2018
Primary Febrile Neutropenia Prophylaxis for Patients Who Receive FEC-D Chemotherapy for Breast Cancer: A Systematic ReviewRicardo Fernandes, Sasha Mazzarello, Carol Stober, et al.Journal of Global Oncology|May 10, 2019
Prospective Survey of Financial Toxicity Measured by the Comprehensive Score for Financial Toxicity in Japanese Patients With CancerKazunori Honda, Bishal Gyawali, Masashi Ando, et al.International Journal of Cancer|June 14, 2021
Assessing population diversity in phase III trials of cancer drugs supporting Food and Drug Administration approval in solid tumorsEmre Yekedüz, Dario Trapani, Wenxin Xu, et al.The Oncologist|April 5, 2019
Trends in Checkpoint Inhibitor Therapy for Advanced Urothelial Cell Carcinoma at the End of Life: Insights from Real-World PracticeRavi B Parikh, Matthew D Galsky, Bishal Gyawali, et al.Plos One|March 22, 2019
Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysisAnne Rossel, Helia Robert-Ebadi, Christophe Combescure, et al.BMJ Oncology|June 16, 2025
Disease-free survival as a surrogate for overall survival in early-stage pancreatic cancer trials: a correlation meta-analysisLuís Felipe Leite, Luiz F Costa de Almeida, Lucas Diniz da Conceição, et al.Critical Reviews in Oncology/Hematology|September 10, 2022
Prognostic scores including peripheral blood-derived inflammatory indices in patients with advanced non-small-cell lung cancer treated with immune checkpoint inhibitorsSara Elena Rebuzzi, Arsela Prelaj, Alex Friedlaender, et al.Pageof 37